Anna Park
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 14
-
- Glycosylation and Glycoproteins Research 7
- Protein purification and stability 2
- Co-authors
- Qun Zhou (5 shared papers)Huawei Qiu (8 shared papers)Clark Q. Pan (5 shared papers)Kerry Culm-Merdek (2 shared papers)Alison McVie‐Wylie (1 shared paper)Srinivas Shankara (1 shared paper)Tim Edmunds (1 shared paper)Scott Estes (1 shared paper)
- Journals
- mAbs (5 papers)Bioconjugate Chemistry (2 papers)Biotechnology and Bioengineering (1 paper)Pharmaceuticals (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Anna Park
14 papers receiving 487 citations
Peers
Comparison fields: 5 of 49
- Radiology, Nuclear Medicine and Imaging 392
- Oncology 166
- Immunology 101
- Molecular Biology 320
- Biotechnology 33
Countries citing papers authored by Anna Park
This map shows the geographic impact of Anna Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Park more than expected).
Fields of papers citing papers by Anna Park
This network shows the impact of papers produced by Anna Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Park. The network helps show where Anna Park may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 177 | |
| 2 | 2007 | 149 | |
| 3 | 2019 | 73 | |
| 4 | 2019 | 22 | |
| 5 | 2021 | 17 | |
| 6 | 2013 | 12 | |
| 7 | 2020 | 11 | |
| 8 | 2013 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2018 | 9 | |
| 11 | 2013 | 9 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 3 | |
| 15 | 2020 | 1 | |
| 16 | 2021 | 0 | |
| 17 | 2015 | 0 |
About Anna Park
Anna Park is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Immunology and Epidemiology, having authored 17 papers that have together received 514 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers), HER2/EGFR in Cancer Research (5 papers), Galectins and Cancer Biology (2 papers), Protein purification and stability (2 papers), T-cell and B-cell Immunology (2 papers), Peptidase Inhibition and Analysis (2 papers) and Thyroid Disorders and Treatments (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (392 citations), Oncology (166 citations), Immunology (101 citations), Molecular Biology (320 citations) and Biotechnology (33 citations). Anna Park has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Qun Zhou, Huawei Qiu, Clark Q. Pan, Kerry Culm-Merdek, Alison McVie‐Wylie, Srinivas Shankara, Tim Edmunds, Scott Estes, André Roy and Julie Bird. Their work appears in journals such as mAbs, Bioconjugate Chemistry, Biotechnology and Bioengineering, Pharmaceuticals and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.